Is Infliximab Effective for Induction of Remission in Patients with Ulcerative Colitis?
Author:
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,Immunology and Allergy
Reference38 articles.
1. Chemokines and cytokines in inflammatory bowel disease and their application to disease treatment
2. Medical Therapy for Crohn's Disease
3. NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE
4. Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model;Health Technology Assessment;2016-05
2. Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies;European Journal of Pharmaceutical Sciences;2013-07
3. New aspects concerning ulcerative colitis and colonic carcinoma: Analysis of levels of neuropeptides, neurotrophins, and TNFalpha/TNFreceptor in plasma and mucosa in parallel with histological evaluation of the intestine;Inflammatory Bowel Diseases;2008-10
4. Is there a role for infliximab in the treatment of severe ulcerative colitis?: The American experience;Inflammatory Bowel Diseases;2008-10
5. Is there a role for infliximab in the treatment of severe ulcerative colitis?;Inflammatory Bowel Diseases;2008-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3